California State Teachers Retirement System Has $7.25 Billion Stake in Agilent Technologies, Inc. $A

California State Teachers Retirement System grew its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 12,343.3% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 54,577,058 shares of the medical research company's stock after purchasing an additional 54,138,451 shares during the period. California State Teachers Retirement System owned about 19.32% of Agilent Technologies worth $7,249,471,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Brighton Jones LLC lifted its stake in Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock valued at $626,000 after acquiring an additional 270 shares in the last quarter. Jones Financial Companies Lllp grew its stake in shares of Agilent Technologies by 15.9% in the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company's stock worth $602,000 after acquiring an additional 769 shares in the last quarter. Geneos Wealth Management Inc. raised its holdings in shares of Agilent Technologies by 54.8% in the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company's stock valued at $70,000 after purchasing an additional 212 shares during the last quarter. Acadian Asset Management LLC raised its holdings in shares of Agilent Technologies by 16.5% in the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company's stock valued at $625,000 after purchasing an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC bought a new position in shares of Agilent Technologies during the second quarter valued at about $273,000. 87.41% of the stock is owned by hedge funds and other institutional investors.

Agilent Technologies Price Performance

A opened at $146.80 on Wednesday. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $163.75. The firm has a 50-day moving average of $142.90 and a 200 day moving average of $128.22. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. The firm has a market cap of $41.39 billion, a P/E ratio of 28.90, a PEG ratio of 2.30 and a beta of 1.24.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating analysts' consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm had revenue of $1.88 billion for the quarter, compared to analysts' expectations of $1.84 billion. During the same period in the previous year, the company earned $1.37 earnings per share. The company's quarterly revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, research analysts expect that Agilent Technologies, Inc. will post 6.2 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on A. Jefferies Financial Group assumed coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They set a "hold" rating and a $135.00 price target on the stock. Royal Bank Of Canada increased their price objective on shares of Agilent Technologies from $155.00 to $185.00 and gave the company an "outperform" rating in a research note on Thursday, August 27th. Stifel Nicolaus lifted their target price on shares of Agilent Technologies from $170.00 to $180.00 and gave the stock a "buy" rating in a research report on Thursday, August 27th. Morgan Stanley boosted their target price on Agilent Technologies from $160.00 to $175.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 12th. Finally, Wall Street Zen raised Agilent Technologies from a "hold" rating to a "buy" rating in a report on Sunday, August 2nd. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $170.33.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.